Skip to main content

Table 4 Comparison of difference in gene expression between combination treatment and mono-treatment in PC3 cells

From: Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells

Gene

Taxotere+Furtulon

 

6 h

36 h

72 h

Decrease in combination treatment, No change or increase in mono-treatment.

   

NM_001261.1 cyclin-dependent kinase 9 (CDC2-related kinase) (CDK9)

-1.3

-1.2

-2.3

NM_016507.1 CDC2-related protein kinase 7 (CrkRS)

NC

-1.6

-2.3

AF080157.1 IkB kinase-a (IKK-alpha)

NC

-2.0

-1.6

U62296.1 transcription factor NF-YC

-1.1

-1.7

-2.3

BC005003.1 nuclear transcription factor Y, gamma

-1.1

-2.0

-2.1

BC001771.1 transcription factor IIF

NC

-1.6

-2.3

AI434345 activating transcription factor 1

NC

-2.5

-2.6

BC001173.1 eukaryotic translation initiation factor 3

NC

-1.3

-2.0

U78525.1 eukaryotic translation initiation factor (eIF3)

NC

-1.4

-2.0

NM_001814.1 cathepsin C (CTSC)

NC

-1.3

-2.0

NM_003377.1 vascular endothelial growth factor B (VEGFB)

-2.1

NC

NC

AF035620.1 BRCA1-associated protein 2 (BRAP2)

-2.3

NC

NC

AF035620.1 BRCA1-associated protein 2 (BRAP2)

-2.3

-2.0

-1.4

NM_005346.2 heat shock 70 kD protein 1B (HSPA1B)

-1.1

-2.1

-1.1

BC000478.1 heat shock 70 kD protein 9B

NC

-1.7

-2.3

NM_014278.1 heat shock protein (hsp110 family) (APG-1)

-1.2

-1.3

-2.0

BC002526.1 Similar to heat shock protein, 110 kDa

-1.1

-1.4

-2.1

Increase in combination treatment, No change or decrease in mono-treatment.

   

NM_000077.1 cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)

NC

1.7

2.1

NM_001262.1 cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)

NC

2.1

2.0

J03202.1 laminin B2 chain mRNA

NC

1.3

2.0

BG164365 microtubule-associated protein 1B

NC

2.3

2.0

NM_000594.1 tumor necrosis factor, member 2

NC

2.5

1.6

NM_001065.1 tumor necrosis factor, member 1A

NC

2.0

1.9

BC000125.1 Similar to transforming growth factor, beta 1

-1.2

1.9

2.1

NM_005649.1 transcription factor 17 (TCF17)

NC

1.1

2.3

NM_005923.2 mitogen-activated protein kinase kinase kinase 5 (MAP3K5)

NC

1.6

2.1

NM_005204.1 mitogen-activated protein kinase kinase kinase 8 (MAP3K8)

NC

2.3

4.3

NM_000785.1 cytochrome P450, subfamily XXVIIB

NC

2.1

1.5

NM_002960.1 S100 calcium-binding protein A3 (S100A3)

NC

2.5

2.5

NM_002962.1 S100 calcium-binding protein A5

NC

8.6

10.6

  1. NC: No change; Negative value: Decrease; Positive value: Increase.
  2. The genes in this list showed a >2 fold change in expression in at least one time point in combination treatment.